Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Rentokil Initial PLC (NYSE:RTO) Stock Rated "Hold" by Wall Street Brokerages

Rentokil Initial logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

Rentokil Initial PLC (NYSE:RTO - Get Free Report) has received an average rating of "Hold" from the thirteen analysts that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $31.90.

A number of research analysts recently commented on the company. Morgan Stanley cut Rentokil Initial from an "overweight" rating to an "equal weight" rating in a report on Tuesday, September 29th. Investec upgraded Rentokil Initial to a "buy" rating in a report on Wednesday, September 23rd. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Rentokil Initial in a report on Monday, August 3rd. BNP Paribas Exane lowered shares of Rentokil Initial from an "outperform" rating to a "neutral" rating and set a $26.70 target price for the company. in a research note on Friday, July 31st. Finally, Stifel Nicolaus raised Rentokil Initial from a "hold" rating to a "buy" rating in a research note on Monday, October 5th.

Check Out Our Latest Analysis on Rentokil Initial

Rentokil Initial Stock Up 0.6%

Shares of NYSE:RTO opened at $21.22 on Tuesday. The company has a current ratio of 1.06, a quick ratio of 0.98 and a debt-to-equity ratio of 0.65. The stock has a 50 day moving average of $22.13 and a 200 day moving average of $27.59. Rentokil Initial has a 12-month low of $19.50 and a 12-month high of $34.67.

Rentokil Initial Cuts Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, September 22nd. Investors of record on Friday, August 14th were given a dividend of $0.2240 per share. The ex-dividend date of this dividend was Friday, August 14th. This is a decrease from Rentokil Initial's previous dividend of $0.4120. This represents a yield of 188.0%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in RTO. Continuum Advisory LLC acquired a new stake in Rentokil Initial during the 2nd quarter worth about $42,000. V Square Quantitative Management LLC increased its holdings in shares of Rentokil Initial by 84.5% during the 1st quarter. V Square Quantitative Management LLC now owns 1,395 shares of the company's stock valued at $44,000 after purchasing an additional 639 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in shares of Rentokil Initial during the 2nd quarter worth about $57,000. Parallel Advisors LLC lifted its position in shares of Rentokil Initial by 50.5% during the 1st quarter. Parallel Advisors LLC now owns 2,107 shares of the company's stock valued at $66,000 after buying an additional 707 shares in the last quarter. Finally, Fifth Third Bancorp acquired a new stake in Rentokil Initial in the 1st quarter worth about $83,000. 9.91% of the stock is owned by institutional investors and hedge funds.

About Rentokil Initial

(Get Free Report)

Rentokil Initial plc NYSE: RTO is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.

The company's pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services.

Recommended Stories

Analyst Recommendations for Rentokil Initial (NYSE:RTO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines